Early Predictors of Success of Non-invasive Positive Pressure Ventilation in Hypercapnic Respiratory Failure

Tilottama Parate, Gayatri Dhote, R. Parate
{"title":"Early Predictors of Success of Non-invasive Positive Pressure Ventilation in Hypercapnic Respiratory Failure","authors":"Tilottama Parate, Gayatri Dhote, R. Parate","doi":"10.25259/vjim_23_2021","DOIUrl":null,"url":null,"abstract":"\n\nTo study the indication of NIPPV in patients with hypercapnic respiratory failure. To evaluate the clinical, laboratory and ventilatory parameters with respect to improvement or deterioration in general condition of the patient. To predict the outcome in the form of weaning from NIPPV or requirement of invasive ventilation. To compare APACHE II score with outcome.\n\n\n\nNon-invasive ventilation (NIV) is now being considered more as the respiratory support of choice for acute respiratory failure. In some patients, with acute hypercapnic respiratory failure, NIV is inadequate and invasive ventilation is required for the management of respiratory failure. Thus, the determination of early predictors of the success of non-invasive positive pressure ventilation (NIPPV) is important to identify the patients who are likely to benefit from it. This study was done to determine the early predictors of the success of NIPPV in hypercapnic respiratory failure.\n\n\n\nIn the current hospital-based prospective observational study, 100 patients admitted with hypercapnic respiratory failure requiring ventilation therapy are included in the study. Baseline clinical (heart rate [HR] and respiratory rate [RR]), arterial blood gas (ABG) parameters (pH, pO2, and pCO2), and ventilatory parameters were recorded before the initiation of NIPPV. The above parameters were re-evaluated at 1, 4, and 24 h after initiation of NIPPV. Acute Physiology and Chronic Health Evaluation II (APACHE II) score was also calculated on admission and at the end of 24 h to compare with the outcome.\n\n\n\nOf the 100 patients, 73% of patients showed improvement in clinical and laboratory parameters. There was an improvement in HR, RR, pH, pCO2, and pO2 within the 1st hour and continued to improve even after 1 h, 4 h, and 24 h of NIPPV in the success group. About 27% of patients who failed to improve required intubation. The optimum cutoff value for APACHE II score on admission for predicting the outcome of NIPPV was found to be 33 in this study. Therefore, a score above 33 predicts failure of NIV.\n\n\n\nThis study demonstrated that the clinical and laboratory parameters predict the success of NIPPV in patients with hypercapnic respiratory failure averting the need for mechanical ventilation.\n","PeriodicalId":232453,"journal":{"name":"Vidarbha Journal of Internal Medicine","volume":"7 2","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vidarbha Journal of Internal Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/vjim_23_2021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

To study the indication of NIPPV in patients with hypercapnic respiratory failure. To evaluate the clinical, laboratory and ventilatory parameters with respect to improvement or deterioration in general condition of the patient. To predict the outcome in the form of weaning from NIPPV or requirement of invasive ventilation. To compare APACHE II score with outcome. Non-invasive ventilation (NIV) is now being considered more as the respiratory support of choice for acute respiratory failure. In some patients, with acute hypercapnic respiratory failure, NIV is inadequate and invasive ventilation is required for the management of respiratory failure. Thus, the determination of early predictors of the success of non-invasive positive pressure ventilation (NIPPV) is important to identify the patients who are likely to benefit from it. This study was done to determine the early predictors of the success of NIPPV in hypercapnic respiratory failure. In the current hospital-based prospective observational study, 100 patients admitted with hypercapnic respiratory failure requiring ventilation therapy are included in the study. Baseline clinical (heart rate [HR] and respiratory rate [RR]), arterial blood gas (ABG) parameters (pH, pO2, and pCO2), and ventilatory parameters were recorded before the initiation of NIPPV. The above parameters were re-evaluated at 1, 4, and 24 h after initiation of NIPPV. Acute Physiology and Chronic Health Evaluation II (APACHE II) score was also calculated on admission and at the end of 24 h to compare with the outcome. Of the 100 patients, 73% of patients showed improvement in clinical and laboratory parameters. There was an improvement in HR, RR, pH, pCO2, and pO2 within the 1st hour and continued to improve even after 1 h, 4 h, and 24 h of NIPPV in the success group. About 27% of patients who failed to improve required intubation. The optimum cutoff value for APACHE II score on admission for predicting the outcome of NIPPV was found to be 33 in this study. Therefore, a score above 33 predicts failure of NIV. This study demonstrated that the clinical and laboratory parameters predict the success of NIPPV in patients with hypercapnic respiratory failure averting the need for mechanical ventilation.
无创正压通气治疗高碳酸血症性呼吸衰竭成功的早期预测因素
目的探讨NIPPV在高碳酸血症性呼吸衰竭患者中的适应证。评估患者一般情况改善或恶化的临床、实验室和通气参数。以NIPPV脱机或需要有创通气的形式预测预后。比较APACHE II评分与预后。无创通气(NIV)现在被更多地视为急性呼吸衰竭的呼吸支持选择。在一些急性高碳酸血症性呼吸衰竭患者中,NIV不充分,需要有创通气来治疗呼吸衰竭。因此,确定无创正压通气(NIPPV)成功的早期预测因素对于确定可能从中受益的患者非常重要。本研究旨在确定NIPPV治疗高碳酸血症性呼吸衰竭成功的早期预测因素。在目前以医院为基础的前瞻性观察性研究中,100例入院的高碳酸血症性呼吸衰竭需要通气治疗的患者被纳入研究。在NIPPV启动前记录基线临床(心率[HR]和呼吸频率[RR])、动脉血气(ABG)参数(pH、pO2和pCO2)和通气参数。在NIPPV启动后1、4和24 h重新评估上述参数。入院时和24 h结束时计算急性生理和慢性健康评估II (APACHE II)评分,并与结果进行比较。在这100名患者中,73%的患者在临床和实验室参数方面表现出改善。成功组的HR、RR、pH、pCO2和pO2在NIPPV治疗1小时内均有改善,并且在NIPPV治疗1、4、24小时后仍有改善。约27%未能改善的患者需要插管。本研究发现,入院时APACHE II评分预测NIPPV预后的最佳临界值为33。因此,分数超过33分预示着NIV的失败。本研究表明,临床和实验室参数预测NIPPV在高碳酸血症性呼吸衰竭患者中的成功,避免了机械通气的需要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信